The surgical management of type IA endoleak after thoracic endovascular aortic repair.

@article{Dun2020TheSM,
  title={The surgical management of type IA endoleak after thoracic endovascular aortic repair.},
  author={Yaojun Dun and Yi Shi and Hongwei Guo and Yanxiang Liu and Xiangyang Qian and Xiaogang Sun and Cuntao Yu},
  journal={Interactive cardiovascular and thoracic surgery},
  year={2020},
  url={https://api.semanticscholar.org/CorpusID:220966123}
}
Different surgical strategies could be selected to treat patients with type Ia endoleak after thoracic endovascular aortic repair (TEVAR), with acceptable early and late outcomes.

Characteristics and risk factors of type I or II endoleaks after thoracic endovascular aortic repair and open surgery

To prevent the occurrence of T1ELs and T2ELs, appropriate stent grafts and the pathology of the LSA should be carefully considered.

Expert opinion: How to treat type IA endoleakage

This expert opinion summarizes the institutional experience with endovascular, open surgical, and hybrid techniques in the context of recent scientific publications to demonstrate the requirement for increasingly patient-tailored treatment strategies and the need for specialized aortic centers.

The surgical management of retrograde type A aortic dissection after thoracic endovascular aortic repair.

Total arch replacement with or without the frozen elephant trunk technique was suitable for the management of RTAD after TEVAR, with acceptable early and long-term results.

Analysis of Risk Factors for Early Type I Endoleaks After Thoracic Endovascular Aneurysm Repair

Risks for early type I endoleaks after TEVAR for aneurysm were landing zone 0–2, LSA coverage, large proximal neck and stent-graft diameters, excessive oversizing, and the use of the chimney technique.

Persistent Type I Endoleak after Endovascular Treatment with Chimney Technique

A case of a type Ia endoleak following TEVAR in the treatment of acute type B aortic dissection and technical success was suboptimal, but the patient remained clinically stable and event free.